News

Refine by category
- Investors
- Press Releases
Refine by year
- 2019
- 2018
- Archive

Press Releases —

ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

07 Nov 2019

Third quarter 2019 revenue of $120 million Third quarter 2019 net loss of $119 million Third quarter 2019 Adjusted EBITDA1 of $56 million Generated cash flows from operating activities of $151 million
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

24 Oct 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 2019 Adjusted EBITDA1 of $60 million Generated cash flow from operating activities of $97 million
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

25 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

24 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Non-Deal Roadshow for European-based Debt Investors

11 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced...
Learn more
Investors —

Corporate Presentation

10 Jun 2019

Find here our corporate presentation with information relating to etc ...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine

23 May 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

16 May 2019

First quarter 2019 revenue of $136 million First quarter 2019 net loss of $8 million First quarter 2019 Adjusted EBITDA1 of $65 million Generated cash flow from operations of $46 million in the...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

14 May 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

01 Apr 2019

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan rights) and Panretin® (alitretinoin) gel 0.1% from Eisai Inc. for $30 million in cash plus approximately $3.3 million for purchased inventory and related prepayments. ADVANZ PHARMA will pay for the acquisition with cash on hand.
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

14 Mar 2019

2018 revenue of $537 million, fourth quarter 2018 revenue of $118 million 2018 net income of $1.5 billion, which includes a $1.9 billion gain on debt settlement as part of the Company's...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

21 Feb 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

30 Jan 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on helping innovate, shape and grow the specialty, off-patent sector in...
Learn more